Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Infection surveillance is an essential epidemiological tool to monitor the health of a population. The major goals of infection surveillance solutions are describing the epidemiology and current burden of disease, monitoring trends, and identifying outbreaks and new pathogens. In addition, infection surveillance solutions provides benefits such as health benefits from limiting cases, disabilities and deaths, as well as social, economic, and psychological benefits which result from preventing outbreaks or monitoring them at an early stage.
Major factors such as well-established United States healthcare industry, increasing expenditure on the healthcare, and positive legislative, strong demand, and technical environment along with solid R&D investments into innovation and development are some of the major factors that accredited to the market growth. In addition, massive presence of global as well as domestic infection surveillance solutions and services providers across the country is further boosting the growth of the market. Furthermore, rising government policies to reduce healthcare associated infection and related disease prevalence is further supporting the market growth across the country.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the infection surveillance solutions market. In addition, complete analysis of changes on infection surveillance solutions market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market. Increasing number of hospitals and clinical laboratories for the diagnosis and the detection of the COVID-19 patient is improving the growth of infection surveillance solutions market. High-throughput technologies are being leveraged by a growing number of hospitals to prevent and control healthcare associated as well as COVID-19 infection spread effectively and rapidly on a wide scale.
The study analyses United States infection surveillance solutions market based on product, and end user.
Based on product, the United States infection surveillance solutions market segmented into software and services segment. The software segment dominated the market in 2021 and is likely to witness rapid growth during the forecast period. The software segment is further sub-segmented into on-premise and web-based. Infection control surveillance software solutions provides a potentially powerful way to combat healthcare associated infections and ability to explore, manage multi user across multiple site, allowing the infection control nurses, ward nurses and senior management to maintain data in different hospital. Moreover, major services such as product support & maintenance services, training & consulting services and implementation services are analyzed in the market.
Major end users of United States infection surveillance solutions market are hospitals, long-term care facilities, others. Hospitals is expected to gain major market share during the forecast period (2019-2028). The hospitals segment include sub-segments such as large hospitals, medium-sized hospitals and small hospitals. An increasing number of hospitals across the country is creating more demand for infection surveillance solutions in the market. For instance, according to the American Hospital Association, in 2019, the total number of all US hospitals was 6,090. Among these the number of number of U.S. community hospitals were 5,141 and Number of Federal Government Hospitals were 208. However, long-term care facilities segment is anticipated to account for second largest share in the market during the projected timeframe. Long term facilities segment include sub-segments such as homecare agencies & hospices, nursing homes and assisted living facilities.
The major key players of market includes Becton Dickson & Company (United States), Baxter International Inc (United States), Premier Inc (United States), Wolters Kluwer N.V (Netherlands), Gojo Industries, Inc (United States), RL Solutions (United States), Truven Health Analytics (An IBM Company) (United States), DEB Group Ltd (United Kingdom), Hygreen, Inc (United States), Vigilanz Corporation (United States), Cerner Corporation (United States), Epic Systems Corporation (United States), Vecna Technologies (United States), Emerald Health Information System (Canada), and PeraHealth Inc (United States) among others.
February 2021: Becton, Dickinson and Company announced collaboration with Scanwell Health for at-home rapid test for COVID-19.
October 2020: RLDatix, the global provider of intelligent patient safety solutions, acquired Verge Health, the recognized best-in-class credentialing software provider. This acquisition joins two companies in the governance, risk, and compliance healthcare software market and dramatically accelerated an essential shift from a reactive approach to risk management to one rooted in safety and prevention.
September 2020: RLDatix announced an agreement with Hill Country Memorial (HCM), a non-profit, acute care community hospital with beds in Fredericksburg, Texas, to implement RLDatix’s Surveillance solution as another step toward adopting the full applied safety intelligence framework.
May 2020: VigiLanz, a clinical surveillance company announced the launch of COVID Quick Start – a new solution which will enable hospitals to prepare for, prevent, and respond to the spread of COVID-19 and other respiratory viral illnesses.
The study analyses United States infection surveillance solutions market based on product, end user, and country. Based on product, the United States infection surveillance solutions market segmented into software and services segment. The software segment is likely to dominate the market over the forecast period. Increased adoption of infection surveillance software solutions in end use industries owing to its several benefits is attributed to the market growth. Major end users of United States infection surveillance solutions market are hospitals, long-term care facilities, others. The hospitals segment is likely to register fastest growth in years to come owing to the increasing number of hospital admissions every year.
Why to buy this report:
